SRZN
#3281
Surrozen, Inc. - Common Stock
24.7 6 USD
-0.17%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-16.60%
Changement Mensuel
+30.11%
Evolution sur 6 mois
-16.86%
Changement Annuel
+82.19%
Clôture Précédente
29.6 9
Open
28.7 0
Low
22.9 4
High
29.9 0
Financials
- Market Capitalization 291.02 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.7
ratio cours/chiffre d'affaires
0.05
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3261 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.74 USD | -3.86% | -1.58% | -18.70% | +194.49% | 298.47 M USD | ||
| 3264 |  QSI Quantum-Si Incorporated - Class A Common Stock | 1.36 USD | -11.11% | +5.43% | +86.30% | -32.34% | 297.68 M USD | ||
| 3293 |  EYPT EyePoint, Inc. - Common Stock | 3.32 USD | -2.35% | +4.40% | -22.61% | -72.33% | 286.22 M USD | ||
| 3295 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.75 USD | -0.53% | +0.81% | -1.83% | -56.40% | 286.11 M USD |